Global Hepatitis B Virus (HBV) Market: 10-Year Demand Forecast (2016-2025) - Koncept Analytics

1
Industry Research by Koncept Analytics
Global Hepatitis B Virus (HBV) Market 10-Year
Demand Forecast ---------------------------------
-------- (2016-2025)
October 2016
2
Executive Summary
Hepatitis B is a virus that infects the liver.
For most adults who suffer from it for a short
time, it is called acute hepatitis B. Sometimes
the virus causes a long-term infection which is
called chronic hepatitis B. Over time, it can
damage the liver. Babies and young children
infected with the virus are more likely to get
chronic hepatitis B. Abdominal pain, fever, dark
urine and joint pain are some of the major
symptoms of hepatitis B. Having a chronic HBV may
lead to serious implications like liver cancer
and liver failure. Keeping the threat in mind,
many governments in the European countries and
the US have made it mandatory for the people to
go through the screening and proper monitoring
since hepatitis B takes time to develop and is
not easily recognizable. There are some curative
therapies available but they are not very
efficient. It is expected that many innovative
therapies which have shown positive results in
trials will occupy the market in the coming
years. Many companies have products related to
hepatitis B in their pipeline. The key factors
driving the growth of hepatitis B market are
increase in liver cancer and cirrhosis deaths,
increasing ageing population, increasing
healthcare expenditure and urbanization leading
to better monitoring and screening procedures.
Some of the noteworthy trends and developments of
this industry are new HBV treatments in
development, government initiative and public
awareness, collaboration, innovation and
research, preference for biomarker based tests.
However, the expansion of hepatitis B market is
hindered by rigid competition, management
challenges, lack of diagnostic facilities and
high cost of medical care and legal
regulations. The report Global Hepatitis B
Market Industry Analysis Outlook (2016-2025)
provides an in-depth analysis of the global
market along with markets of the US and Europe.
The major trends, growth drivers as well as
issues being faced by the industry are being
presented in this report. The industry comprises
large players such as Arrowhead, Arbutus, Gilead
and Johnson Johnson. All these companies have
been profiled in the present report highlighting
their key financials and business strategies for
growth.
3
The factors driving the growth of hepatitis B
market are increase in liver cancer and cirrhosis
deaths, increasing ageing population, increasing
healthcare expenditure and urbanization leading
to better monitoring and screening procedures
Global HBV Market Forecast by Value (2016-2025)

• The global HBV market is forecasted to be US....
  billion in the year 2016 which is expected to
  reach US..... billion by 2025.
• The market value of HBV in the US is expected to
  increase to US.... billion in 2025 from US....
  billion in 2016.
• The number of chronic HBV patients is expected
  to be .. thousands in 2016 which is expected to
  increase to thousands by 2025.

The US HBV Market Forecast by Value (2016-2025)
The US Chronic HBV Patients Forecast by Volume
(2016-2025)
4
New HBV treatments in development, government
initiative and public awareness, collaboration,
innovation and research, preference for biomarker
based tests are the latest trends in the industry.
The US Diagnosed HBV Patients Forecast by Volume
(2016-2025)

• The number of people diagnosed with HBV is
  expected to increase to thousands by 2025 from
  ..thousands in 2016.
• It is forecasted that the market value of HBV in
  Japan will increase to US.... billion by 2025
  increasing from US..... billion in 2016.
• The HBV market value in European Union is
  forecasted to increase to US..... billion by
  2025 from US..... billion in 2016.

EU HBV Market Forecast by Value (2016-2025)
Japan HBV Market Forecast by Value (2016-2025)
5
Disclaimer
Contact Us
This is a licensed product of Koncept Analytics.
You cannot reproduce, publish, distribute,
publicly display, sell or create other works from
this report or use them in any way for commercial
purpose without our prior permission. Further,
you cannot copy this material, by any means
(including electronic copies), for distribution
to others unless you have purchased the corporate
license of this report. We believe the sources
are reliable, but Koncept Analytics does not
warranty the accuracy or completeness of the
data. The data presented in the report is updated
at the publication date but is subject to change
at subsequent releases. All possible efforts have
been made to ensure accuracy of data. However,
investors should not completely rely on the
information given in this report and must make
decisions based on their own investment strategy,
risk management and capital adequacy.
Koncept Analytics CS-36, First Floor, Ansal
Plaza Vaishali, Ghaziabad, U.P. 201010 T
91-120-4130959 M 91-9811715635
vikas_at_konceptanalytics.com
www.konceptanalytics.com